# Progress Note 04 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Winston Churchill (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET001-SYN
- Date: 2026-08-19
- Fictional facility: St. Posthumous Health Center
- Fictional author: Beatrice Okafor, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Eight-week stroke and blood pressure review. **S**

## History of present illness

Mr. Churchill returns eight weeks after his stroke and three weeks after the sick visit at which amlodipine was reduced to 5 mg for orthostatic lightheadedness. The lightheadedness resolved within two days, and his home standing pressures have been 120 to 130 systolic. He has had no falls and no new neurological symptoms. He walks outdoors without a stick and his handwriting is nearly normal. He has started chairing meetings at work again, for half days. The 30-day heart monitor was returned five days ago. He is down to about four cigars a day and no longer drinks in the afternoon. His mood is better and he cries less often. **S**

| Element | Detail |
|---|---|
| Interval change | Orthostatic symptoms resolved after reducing amlodipine |
| Function | Walking outdoors without a stick; handwriting nearly normal; half days at work |
| Home blood pressure | Standing 120 to 130 systolic |
| Tobacco and alcohol | About four cigars a day; no afternoon drinking |
| Mood | Better; tearful less often |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Energy improving |
| Cardiovascular | Negative | No lightheadedness, chest pain, or palpitations |
| Neurological | Negative | No new weakness, numbness, speech change, or visual loss |
| Musculoskeletal | Negative | No muscle aches on atorvastatin |
| Psychiatric | Negative | Mood improving; sleeping better; no thoughts of self-harm; PHQ-9 score 6 |

5 systems reviewed. **S**

## Current medications

- Clopidogrel 75 mg oral tablet, one tablet by mouth daily (after a 300 mg loading dose in the hospital) **S**
- Atorvastatin 80 mg oral tablet, one tablet by mouth daily **S**
- Lisinopril 5 mg oral tablet, one tablet by mouth daily **S**
- Amlodipine 5 mg oral tablet, one tablet by mouth daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 128/76 mmHg; pulse 70 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 97% on room air; weight 79 kg; BMI 28 kg/m². All vital signs are synthetic.

Total cholesterol: 128 mg/dL; HDL cholesterol: 48 mg/dL; Triglycerides: 110 mg/dL; LDL cholesterol: 58 mg/dL; ALT: 28 U/L; PHQ-9: 6; AUDIT-C: 5. All results are synthetic.

## Change since baseline

- ALT: 30 U/L at baseline, 28 U/L at this visit **S**
- PHQ-9: 8 at baseline, 6 at this visit **S**
- AUDIT-C: 8 at baseline, 5 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well and animated |
| Orthostatic vital signs | Seated 128/76 mmHg; standing 124/74 mmHg, no symptoms |
| Heart | Regular rhythm; no murmur |
| Neurological | Faint left pronator drift only; speech normal |
| Gait | Normal pace without a stick; slight left circumduction when tired |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Lacunar stroke eight weeks ago, recovering well** (I69.354). The 30-day monitor showed no atrial fibrillation, so antiplatelet therapy remains correct. LDL cholesterol 58 mg/dL on atorvastatin 80 mg, below the 70 mg/dL target. Mood improving (PHQ-9 down from 8 to 6). **S**
   - Continue clopidogrel and atorvastatin.
   - Continue physical and occupational therapy until discharge.
   - Increase work gradually toward full days over the next six weeks.
2. **Essential hypertension** (I10). Blood pressure 128/76 mmHg seated without orthostatic fall on amlodipine 5 mg and lisinopril 5 mg. Potassium and creatinine at the sick visit, two weeks after starting lisinopril, were acceptable. **S**
   - No change.
   - Basic metabolic panel every six months.
3. **Nicotine dependence, cigars** (F17.290). About four cigars a day. **S**
   - Goal of three a day agreed as a step toward stopping.
4. **Unhealthy alcohol use**. AUDIT-C down from 8 to 5; no longer six or more drinks on one occasion. **S**
   - Continue to aim for no more than two drinks a day.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Blood pressure seated and standing, weight and BMI | Every visit | Completed today | Seated 128/76 mmHg, standing 124/74 mmHg; weight 79.0 kg; target met without orthostatic hypotension |
| Laboratory | Lipid panel | 4 to 12 weeks after starting or changing a statin, then every 3 to 12 months | Completed today | Eight weeks after starting atorvastatin 80 mg. LDL cholesterol 58 mg/dL, below the 70 mg/dL target |
| Laboratory | ALT | Baseline, then only with symptoms | Completed today | 28 U/L, normal |
| Laboratory | Basic metabolic panel | 1 to 2 weeks after starting an ACE inhibitor, then every 6 months | Up to date | Drawn at the sick visit two weeks after lisinopril was started: potassium 4.6, creatinine 1.12 mg/dL; next in about six months |
| Imaging | Prolonged cardiac rhythm monitoring | At least 30 days within 6 months of the stroke | Completed today | 30 days of monitoring reviewed: sinus rhythm throughout, no atrial fibrillation or flutter |
| Medication safety | Antithrombotic and statin adherence | Every visit | Completed today | Taking clopidogrel and atorvastatin; no bleeding or myalgia |
| Examination | Fall-risk assessment | Every visit | Completed today | One near-fall with orthostatic hypotension three weeks ago; none since |
| Survey | Depression screen (PHQ-9) | First post-stroke visit, then periodically while symptoms persist; at least yearly | Completed today | 6, down from 8; item 9 scored 0; no treatment needed |
| Survey | Alcohol use (AUDIT-C) | Every visit | Completed today | 5, down from 8; brief intervention repeated |
| Self-management | Tobacco use | Every visit | Completed today | About four cigars a day; goal of three agreed |
| Examination | Obstructive sleep apnea evaluation | Consider for all after stroke | Deferred | STOP-Bang 3 (age, sex, and hypertension), with no loud snoring, witnessed apneas, or sleepiness beyond his habitual afternoon nap. Sleep testing was offered and he declined it for now, a deviation from the protocol recorded here. No harm is evident; corrective action: the question will be asked again at each review and testing arranged if symptoms appear |
| Referral | Physical and occupational therapy | Through recovery | Completed today | Continuing; expected discharge next month |
| Survey | Cognitive screen (MoCA) | Again within the first year | Due | Planned at the annual wellness visit |
| Medication safety | Influenza vaccination | Yearly | Due | This season's vaccine due in the autumn |

## Goal progress

- Lower blood pressure below 130/80 mmHg without orthostatic symptoms by the eight-week review. Outcome by 2026-08-19: Blood pressure 128/76 mmHg on amlodipine 5 mg and lisinopril 5 mg; no orthostatic fall. **S**
- Lower LDL cholesterol below 70 mg/dL by the eight-week review. Outcome by 2026-08-19: LDL cholesterol 58 mg/dL on atorvastatin 80 mg. **S**
- Return to full work and public speaking by about three months after the stroke. In progress; target 2026-10-07. **S**
- Keep to no more than two drinks on any day. In progress; target 2026-10-07. **S**
- Cut down to three cigars a day as a step toward stopping. In progress; target 2026-10-07. **S**

## Guideline basis

- 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack (2021), American Heart Association and American Stroke Association
- Primary Care of Adult Patients After Stroke: A Scientific Statement From the American Heart Association/American Stroke Association (2021), American Heart Association and American Stroke Association
- 2024 ACC Expert Consensus Decision Pathway on Practical Approaches for Arrhythmia Monitoring After Stroke (2024), American College of Cardiology
- CMID: Clinical Monitoring Intelligence Database, stroke/TIA, hypertension, and depression monographs (2026), Aether Forge

## Follow-up

- Three-month stroke review in about seven weeks. **S**
- Next scheduled visit 2026-10-07: three-month stroke review before returning to public speaking. **S**
